News
Latest events and news!
Bridge pharma
You can find the recent updates about us below.
Bridge signs a distribution agreement with Iraqi partner
Ekleel Al Saha is our partner in Iraq since 2019. Ekleel has risen to the top of the market of their region in gynecology line especially for treating polycystic ovary syndrome (PCOS), by using our inositol containing product, Inoself.
Which had a huge impact on the outcome of this disease. Our partner has distributed the Inoself to almost all healthcare centers , clinics and hospitals in Iraq, and they have received lots of approvals through the outstanding feedbacks from the patients and doctors.
Replenitol is what patients looking for and doctors want!
One of the major disadvantages of taking inositol in sachet form is patient compliance and daunting adverse effects related to it. We have made an innovation by forming the first Inositol tablet in the world.
Half of women in a major trial using a competitor’s sachets could not complete treatment with the researchers noting that they “made many of them sick!”
We introduced Replenitol tablets 30 months ago and they have been very well-received almost unanimously. They are more convenient, more closely mimic your body’s natural blood levels and have higher bio-availability. By contrast, the largest study into the benefits of inositol met with severe challenges as many women withdrew from the EMmy trial after attributing nausea and vomiting to the sachets that were used in the trial.
Starting registration with JFDA
Jordan Food and Drug Administration (JFDA) was established
in 2003 as the sole national competent authority for drug safety and efficacy,
as well as food quality and safety in Jordan.
Our partner in Jordan, Glocal Local Medical has started the process
of registering our products with JFDA which is one of the essential steps in
the medical importation to Jordan. Once they finish the registration process,
our products will be ready to be launched in Jordan and women with PCOS and
physicians will benefit from its proven results.
Attending Arab health 2020
Arab Health is the largest healthcare event in the Middle East. Over 5,000 exhibitors utilize this show as a launch platform for new products and services as well as showcasing new developments.
The main goal of this event is to connect manufacturers and service providers with clinicians, procurement professionals, dealers and distributors.
We have attended this event in the past 2 years, where we gained insight of the MENA healthcare market and collected necessary leads to develop our business in the rest of the Middle East market.
Superfolate, new way of supplementing Folic Acid
Folic acid is one of the essential vitamins that is needed for the proper cell division, normal fetal development and a healthy pregnancy. Its defficiencey is proven to have detremental affects on the newborn including Neural Tube Defect, cleft lip and palate and other congenital anomalies. The new active form of folic acid, namely Methyl folate (5 – MTHF) is the metabolically active form of folic acid that can participate in the DNA synthesis with out any need for conversion or metabolic change. It is the ready form that can be used by the body cells.